• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

RAND Study Highlights Challenges Facing the US Blood Supply

November 30, 2016

USA Map

The RAND Corporation conducted a study examining the United States’ blood supply system. Data was collected from interviews with 9 blood centers, 8 hospitals, and 11 corporations that supply equipment for blood collection centers.  Interviews were also conducted with 6 governmental agencies including the Department of Health and Human Services.  The RAND report noted a decreased demand for blood, shrinking donor pools, reduced profits, vulnerabilities of the blood supply to emerging infectious diseases and public health emergencies, and a lack of a central hemovigilance reporting system.  Based on their findings, they recommend the need for a more comprehensive system to collect data on blood use and hemovigilance reporting.  A national plan for emergency preparedness, including funding, should be developed.  The report also stressed the importance of investing in new technology.  Although the US blood supply system has challenges, the study found it to be effective and efficient.  The RAND study investigators are optimistic that the US blood supply will continue to be sustainable.

 

References:

  1. Mulcahy, Andrew W., Kandice A. Kapinos, Brian Briscombe, Lori Uscher-Pines, Ritika Chaturvedi, Spencer R. Case, Jakub Hlavka and Benjamin M. Miller. Toward a Sustainable Blood Supply in the United States: An Analysis of the Current System and Alternatives for the Future. Santa Monica, CA: RAND Corporation, 2016. http://www.rand.org/pubs/research_reports/RR1575.html. Also available in print form.  

 

 

Filed Under

  • News
  • Policy and Guidelines

Recommended

  • ASFA Issues Updated Recommendations

  • Platelet-Rich Plasma Injections Do Not Reduce Tendon Dysfunction in Patients with Chronic Midportion Achilles Tendinopathy

  • Platelet Transfusion Use in the United States

Show Comments

Comments on this article are closed.

Get the latest news. Subscribe to our mailing list. Sign Up

Primary Sidebar

Latest News

  • Cryopreserved vs. Standard Platelets for Surgical Bleeding

  • Phosphatidylserine and Phosphatidylethanolamine Levels on RBCs Important for Transfusion Outcomes

  • Blood Donation and Improved Cardiometabolic Health

  • Mitochondrial DNA Acts as a “First Hit” for Antibody-Mediated TRALI

    Question of the Day

    Copyright © 2026 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley